Revumenib
syndax pharma
['revumenib', 'augment,trial', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)', 'augment,data', 'aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)', 'augment-101', 'leukemia', '#all ,(-alli),(-allogenic)', 'syndax']
we are excited to be at #ash22 today presenting positive data in two oral presentations from the phase 1 portion of the augment-101 trial of #revumenib in r/r acute leukemias. read about the data at: #clinicaltrials #aml #all 
Syndax is a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies.